Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells

Journal of Hepatology

Volumn 30, Issue 4, 1999, Pages 621-631

  Desmoulière, Alexis ^a   Xu, Guoxiong ^c   Costa, Andréa M A ^b,d   Yousef, Ibrahim M ^e   Gabbiani, Giulio ^c   Tuchweber, Beatriz ^e  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cholestatic injury; Desmin; Fibrosis; Hepatic stellate cell; Myofibroblast; Smooth muscle actin

Indexed keywords

ACETONE; CARBON TETRACHLORIDE; DESMIN; PENTOXIFYLLINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CELL CULTURE; CELL PROLIFERATION; CHOLESTATIC HEPATITIS; FIBRINOGEN BLOOD LEVEL; INFLAMMATION; LIVER CELL; LIVER FIBROSIS; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE;

EID: 0033030541     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80192-5     Document Type: Article

References (44)

1. Ramadori G. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell. Virchows Arch B Cell Pathol. 61:1991;147-158.
2. Pinzani M. Novel insight into the biology and physiology of the Ito cell. Pharmacol Ther. 66:1995;387-412.
3. Tuchweber B., Desmoulière A., Bochaton-Piallat M.L., Rubbia-Brandt L., Gabbiani G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest. 74:1996;265-278.
4. Peterson T.C. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology. 17:1993;486-493.
5. Hodgson P.D., Peterson T.C. Effect of pentoxifylline in a heterologous serum model of fibrosis in the rat. [abstract] Hepatology. 22:(4pt2):1995;429A.
6. Rubio M., Parés A., Gassó M., Giménez A., Deulofeu R., Caballería J., et al. Pentoxifylline prevents liver fibrosis but induces cellular damage in carbon tetrachloride injured rats. [abstract] J Hepatol. 21:1994;S136.
7. Boigk G., Raetsch C., Stroeter L., Waldschmidt J., Herbst H., Riecken E.O., et al. Antifibrotic effect of pentoxifylline in rat biliary fibrosis due to bile duct obstruction. [abstract] J Hepatol. 23:(suppl 1):1995;142.
8. Peterson T.C., Neumeister M. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism. Immunopharmacology. 31:1996;183-193.
9. Oberti F., Pilette C., Rifflet H., Maïga M.Y., Moreau A., Gallois Y., et al. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation. J Hepatol. 26:1997;1363-1371.
10. Park E.J., Ko G., Kim J., Sohn D.H. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull. 20:1997;417-420.
11. Raetsch C., Boigk G., Stroeter L., Waldschmidt J., Herbst H., Riecken E.O., et al. Pentoxifyllin inhibits hepatic collagen deposition in early but not advanced rat biliary fibrosis. [abstract] Gastroenterology. 110:1996;A1301.
12. Berman B., Matthew R., Duncan R. Pentoxifylline inhibits normal human dermal fibroblasts in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol. 92:1989;605-610.
13. Berman B., Duncan M.R. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol. 123:1990;339-346.
14. Chang C.C., Chang T.C., Kao S.C.S., Kuo Y.F., Chien L.F. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema. Acta Endocrinol. 129:1993;322-327.
15. Duncan M.R., Hasan A., Berman B. Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. J Invest Dermatol. 104:1995;282-286.
16. 4 or bile duct obstruction in rats. Wisse E., Knook D.L., Balabaud C., Cells of the Hepatic Sinusoid, Vol 6. 1997;48-49 Kupffer Cell Foundation, Leiden.
17. Charbonneau M., Tuchweber B., Plaa G.L. Acetone potentiation of chronic liver injury induced by repetitive administration of carbon tetrachloride. Hepatology. 6:1986;694-700.
18. Skalli O., Ropraz P., Trzeciak A., Benzonana G., Gillessen D., Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 103:1986;2787-2796.
19. Kocher O., Skalli O., Bloom W.S., Gabbiani G. Cytoskeleton of rat aortic smooth muscle cells: normal conditions and experimental intimal thickening. Lab Invest. 50:1984;645-652.
20. Xu G., Niki T., Virtanen I., Rogiers V., De Bleser P., Geerts A. Gene expression and synthesis of fibronectin isoforms in rat hepatic stellate cells. Comparison with liver parenchymal cells and skin fibroblasts. J Pathol. 183:1997;90-98.
21. Xu G., Redard M., Gabbiani G., Neuville P. Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. Am J Pathol. 151:1997;1741-1749.
22. Sambrook J., Fristch E.J., Maniatis T. Extraction, purification and analysis of messenger RNA from eukaryotic cells. Sambrook J., Fristch E.J., Maniatis T., Molecular Cloning. A Laboratory Manual, 2nd ed. 1989;7.37-7.52 Cold Spring Harbor Laboratory Press, New York.
23. Kocher O., Gabbiani G. Analysis of α-smooth-muscle actin mRNA expression in rat aortic smooth-muscle cells using a specific cDNA probe. Differentiation. 34:1987;201-209.
24. Bochaton-Piallat M.L., Gabbiani F., Ropraz P., Gabbiani G. Cultured aortic smooth muscle cells from newborn and adult rats show distinct cytoskeletal features. Differentiation. 49:1992;175-185.
25. Desmoulière A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 122:1993;103-111.
26. Newberne P.M., Newberne J.W. Morphologic characteristics of chemical-induced hepatotoxicity in laboratory rodents. Plaa G.L., Hewitt W.R., Toxicology of the Liver, 2nd ed. 1998;61-91 Taylor & Francis, Washington.
27. Desmoulière A., Darby I., Costa A.M.A., Raccurt M., Tuchweber B., Sommer P., et al. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest. 76:1997;765-778.
28. Ramadori G., Veit T., Schwogler S., Dienes H.P., Knittel T., Rieder H., et al. Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol. 59:1990;349-357.
29. Desmoulière A., Gabbiani G. The role of the myofibroblast in wound healing and fibrocontractive diseases. Clark R.A.F., The Molecular and Cellular Biology of Wound Repair, 2nd ed. 1996;391-423 Plenum Press, New York.
30. Préaux A.M., Mallat A., Rosenbaum J., Zafrani E.S., Mavier P. Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells. Hepatology. 26:1997;315-322.
31. Romanelli R.G., Caligiuri A., Carloni V., DeFranco R., Montalto P., Ceni E., et al. Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-β1. Br J Pharmacol. 122:1997;1047-1054.
32. Desmoulière A., Rubbia-Brandt L., Abdiu A., Walz T., Macieira-Coelho A., Gabbiani G. α-Smooth muscle actin is expressed in a sub-population of cultured and cloned fibroblasts and is modulated by γ-interferon. Exp Cell Res. 201:1992;64-73.
33. Pittet B., Rubbia-Brandt L., Desmoulière A., Sappino A.P., Roggero P., Guerret S., et al. Effect of γ-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study. Plast Reconstr Surg. 93:1994;1224-1235.
34. Dans M.J., Isseroff R. Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha, -beta, and -gamma. J Invest Dermatol. 102:1994;118-121.
35. Peterson T.C., Isbrucker R.A., Hooper M.L. In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. Immunopharmacology. 28:1994;259-270.
36. Pinzani M., Marra F., Caligiuri A., DeFranco R., Gentilini A., Failli P., et al. Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells. Br J Pharmacol. 119:1996;1117-1124.
37. Isbrucker R.A., Peterson T.C. Platelet-derived growth factor and pentoxifylline modulation of collagen synthesis in myofibroblasts. Toxicol Appl Pharmacol. 149:1998;120-126.
38. Berman B., Wietzerbin J., Sanceau J., Merlin G., Duncan M.R. Pentoxifylline inhibits certain constitutive and tumor necrosis factor induced activities of human normal dermal fibroblasts. J Invest Dermatol. 98:1992;706-712.
39. Currin R.T., Lictman S.N., Thurman R.G., LeMasters J.J. Pentoxifylline, adenosine, prostaglandin E-1 and nisoldipine inhibit tumor necrosis factor release from LPS stimulated rat Kupffer cells. [abstract] Hepatology. 14:1991;165.
40. Britton R.S., Bacon B.R. Role of free radicals in liver diseases and hepatic fibrosis. Hepato-Gastroenterol. 41:1994;343-348.
41. Kozaki K., Egawa H., Bermudez L., Feduska N.J., So S.K., Esquivel C.O. Pentoxifylline inhibits production of superoxide anion and tumor necrosis factor by Kupffer cells in rat liver preservation. Transplant Proc. 25:1993;3025-3026.
42. Kozaki K., Egawa H., Bermudez L., Keefe E.B., So S.K., Esquivel C.O. Effects of pentoxifylline pretreatment on Kupffer cells in rat liver transplantation. Hepatology. 21:1995;1079-1082.
43. Lee K.S., Buck M., Houglum K., Chojkier M. Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest. 96:1995;2461-2468.
44. Lee K.S., Cottam H.B., Houglum K., Wasson D.B., Carson D., Chojkier M. Pentoxifylline blocks hepatic stellate cell activation independently of phosphodiesterase inhibitory activity. Am J Physiol. 273:1997;G1094-G1100.